• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体干细胞移植大剂量化疗10年后长期淋巴瘤幸存者的就业模式及相关因素

Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.

作者信息

Kiserud C E, Fagerli U-M, Smeland K B, Fluge Ø, Bersvendsen H, Kvaløy S, Holte H, Dahl A A

机构信息

a National Advisory Unit for Late Effects After Cancer, Department of Oncology , Oslo University Hospital, Radiumhospitalet , Oslo , Norway ;

b Department of Oncology , St. Olav's Hospital , Trondheim , Norway ;

出版信息

Acta Oncol. 2016 May;55(5):547-53. doi: 10.3109/0284186X.2015.1125015.

DOI:10.3109/0284186X.2015.1125015
PMID:27123741
Abstract

Background This study examined employment patterns and associated factors in lymphoma survivors treated with high-dose chemotherapy with autologous stem cell transplantation (HDT-ASCT) from diagnosis to a follow-up survey at a mean of 10 years after HDT-ASCT. Patients and methods All lymphoma survivors aged ≥18 years at HDT-ASCT in Norway from 1987 to 2008, and alive at the end of 2011 were eligible for this cross-sectional study performed in 2012/2013. Participants completed a mailed questionnaire. Job status was dichotomized as either employed (paid work) or not-employed (disability and retirement pension, on economic support, home-makers, or students). Results The response rate was 78%, and the sample (N = 312) contained 60% men. Mean age at HDT-ASCT was 44.3 and at survey 54.0 years. At diagnosis 85% of survivors were employed, 77% before and 77% after HDT-ASCT, and 58% at follow-up. Forty seven percent of the survivors were employed at all time points. The not-employed group at survey was significantly older and included significantly more females than the employed group. No significant between-group differences were observed for lymphoma-related variables. Fatigue, mental distress and type D personality were significantly higher among those not-employed, while quality of life was significantly lower compared to the employed group. Older age at survey, being female, work ability and presence of type D personality remained significantly related to being not-employed at survey in the multivariable analysis. Conclusions Our findings show that not-employed long-term survivors after HDT-ASCT for lymphoma have more comorbidity, cognitive problems and higher levels of anxiety/depression than employed survivors. These factors should be checked and eventually treated in order to improve work ability.

摘要

背景 本研究调查了接受高剂量化疗联合自体干细胞移植(HDT-ASCT)的淋巴瘤幸存者从诊断到HDT-ASCT后平均10年随访调查期间的就业模式及相关因素。

患者与方法 纳入1987年至2008年在挪威接受HDT-ASCT时年龄≥18岁且在2011年底仍存活的所有淋巴瘤幸存者,于2012/2013年进行这项横断面研究。参与者完成一份邮寄问卷。就业状况分为就业(有薪工作)或未就业(残疾和退休养老金领取者、依靠经济资助者、家庭主妇或学生)。

结果 应答率为78%,样本(N = 312)中60%为男性。HDT-ASCT时的平均年龄为44.3岁,调查时为54.0岁。诊断时85%的幸存者有工作,HDT-ASCT前和后分别为77%,随访时为58%。47%的幸存者在所有时间点均有工作。调查时未就业组的年龄显著更大,女性比例显著高于就业组。淋巴瘤相关变量在两组之间未观察到显著差异。未就业者的疲劳、精神困扰和D型人格显著更高,而生活质量与就业组相比显著更低。在多变量分析中,调查时年龄较大、女性、工作能力和D型人格的存在与调查时未就业仍显著相关。

结论 我们的研究结果表明,接受HDT-ASCT治疗的淋巴瘤长期未就业幸存者比就业幸存者有更多合并症、认知问题和更高水平的焦虑/抑郁。这些因素应进行检查并最终治疗以提高工作能力。

相似文献

1
Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.自体干细胞移植大剂量化疗10年后长期淋巴瘤幸存者的就业模式及相关因素
Acta Oncol. 2016 May;55(5):547-53. doi: 10.3109/0284186X.2015.1125015.
2
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.大剂量化疗联合自体造血干细胞移植治疗淋巴瘤后幸存者的治疗后工作模式。
BMC Cancer. 2021 Feb 8;21(1):143. doi: 10.1186/s12885-021-07836-2.
3
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.接受高剂量疗法联合自体干细胞移植治疗的长期淋巴瘤幸存者,其骨密度与同龄人相比接近正常水平。
Acta Oncol. 2017 Apr;56(4):590-598. doi: 10.1080/0284186X.2016.1267870. Epub 2017 Jan 12.
4
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.淋巴瘤患者在接受大剂量自体造血干细胞移植后的生活方式行为,通过患者报告的结果进行评估。
Acta Oncol. 2019 May;58(5):690-699. doi: 10.1080/0284186X.2018.1558370. Epub 2019 Jan 30.
5
Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.大剂量自体干细胞移植后长期淋巴瘤幸存者的阻塞性和限制性肺功能障碍。
Acta Oncol. 2018 Jun;57(6):773-781. doi: 10.1080/0284186X.2017.1406137. Epub 2017 Nov 24.
6
Early retirement and non-employment after breast cancer.乳腺癌患者的提前退休和非就业。
Psychooncology. 2014 Jun;23(6):634-41. doi: 10.1002/pon.3459. Epub 2013 Dec 18.
7
Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study.接受自体干细胞移植治疗的淋巴瘤幸存者的瓣膜功能障碍:一项全国性横断面研究。
JACC Cardiovasc Imaging. 2016 Mar;9(3):230-9. doi: 10.1016/j.jcmg.2015.06.028. Epub 2016 Feb 17.
8
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.老年非霍奇金淋巴瘤患者接受大剂量治疗及自体干细胞移植的良好预后。
Biol Blood Marrow Transplant. 2014 Dec;20(12):2004-9. doi: 10.1016/j.bbmt.2014.08.019. Epub 2014 Aug 28.
9
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. upfront 自体干细胞移植在外周 T 细胞淋巴瘤中的应用:NLG-T-01
J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.
10
[High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].[霍奇金淋巴瘤患者自体干细胞移植大剂量治疗:单中心治疗患者的长期随访]
Cas Lek Cesk. 2006;145(1):19-24.

引用本文的文献

1
Longitudinal study of cognitive and mental functions among adult Hodgkin-lymphoma survivors, based on data from a primary treatment center in Hungary.基于匈牙利一家主要治疗中心的数据,对成年霍奇金淋巴瘤幸存者的认知和心理功能进行的纵向研究。
Front Oncol. 2025 Feb 17;15:1509424. doi: 10.3389/fonc.2025.1509424. eCollection 2025.
2
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors.德国血液癌幸存者中,职业活动受损和经济问题较为常见。
Sci Rep. 2023 Dec 21;13(1):22856. doi: 10.1038/s41598-023-50289-9.
3
Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States.
在美国 III/IV 期经典型霍奇金淋巴瘤中,ECHELON-1 总生存对生产力成本的估计影响。
J Manag Care Spec Pharm. 2023 Dec;29(12):1312-1320. doi: 10.18553/jmcp.2023.23101. Epub 2023 Nov 3.
4
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects.长期霍奇金淋巴瘤幸存者的工作能力和工作状况变化,重点关注晚期不良效应。
J Cancer Surviv. 2024 Dec;18(6):1921-1930. doi: 10.1007/s11764-023-01432-y. Epub 2023 Aug 1.
5
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study.淋巴瘤后的工作残疾与重返工作岗位:一项丹麦全国队列研究。
Clin Epidemiol. 2023 Mar 14;15:337-348. doi: 10.2147/CLEP.S399488. eCollection 2023.
6
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis.癌症诊断与治疗后的失业状况:一项系统评价与荟萃分析
Cancers (Basel). 2023 Feb 28;15(5):1513. doi: 10.3390/cancers15051513.
7
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation.造血细胞移植幸存者以患者为中心的结果——重返工作的患病率及影响因素
Curr Hematol Malig Rep. 2022 Dec;17(6):228-242. doi: 10.1007/s11899-022-00678-0. Epub 2022 Oct 4.
8
Investigating how cancer-related symptoms influence work outcomes among cancer survivors: a systematic review.调查癌症相关症状如何影响癌症幸存者的工作结果:系统评价。
J Cancer Surviv. 2022 Oct;16(5):1065-1078. doi: 10.1007/s11764-021-01097-5. Epub 2021 Aug 23.
9
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.大剂量化疗联合自体造血干细胞移植治疗淋巴瘤后幸存者的治疗后工作模式。
BMC Cancer. 2021 Feb 8;21(1):143. doi: 10.1186/s12885-021-07836-2.
10
Long-term work retention after treatment for cancer: a systematic review and meta-analysis.癌症治疗后的长期工作保留:系统评价和荟萃分析。
J Cancer Surviv. 2020 Apr;14(2):135-150. doi: 10.1007/s11764-020-00862-2. Epub 2020 Mar 11.